Jennifer McKenzie
Senior Clinical Program Leader Boehringer Ingelheim
Seminars
Wednesday 19th August 2026
Panel Discussion: Integrating the Patient Voice into Rare Kidney Disease Drug Development through Trial Design, Endpoint Selection, & Treatment Delivery to Improve Therapy Adoption & Satisfaction
4:30 pm
- Incorporating patient perspectives early in drug development to ensure therapies address meaningful outcomes such as disease progression, dialysis avoidance, and quality of life
- Incorporating patient priorities and lived experience into therapy design and development strategies
- Understanding treatment burden, delivery preferences, and risk tolerance from the patient perspective
Thursday 20th August 2026
Clinical Trial Design Considerations for Small Populations in Rare Kidney Disease
10:30 am
- Building multi-stakeholder alignment to advance clinical trial design in small kidney disease populations
- Moving beyond the status quo with bold, innovative approaches for rare population trials
- Embedding patient voice and pragmatic design principles to make trials feasible and meaningful
